EQT Life Sciences
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio4 active
1Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Electra Therapeutics
6Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Electra Therapeutics | Biotech | Active | Oct 30, 2025 | $134.2M |
| ATB Therapeutics | Biotech | Active | — | — |
| Exciva | Biotech | Active | — | — |
| PanTera | Biotech | Active | — | — |
| Tubulis | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#160
Raises, 12 months#22
Co-investors#188
Co-investors
- Andera PartnersVenture capital2 shared
- Deep Track CapitalVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- OrbiMedVenture capital1 shared
- SeagenVenture capital1 shared
- Venrock Healthcare Capital PartnersVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.